Phase II trial of oral etoposide plus intravenous irinotecan in patients with platinum-resistant and taxane-pretreated ovarian cancer (JCOG0503)

Koji Matsumoto, Noriyuki Katsumata, Taro Shibata, Toyomi Satoh, Motoaki Saitou, Mayu Yunokawa, Tadao Takano, Kenichi Nakamura, Toshiharu Kamura, Ikuo Konishi

Research output: Contribution to journalArticle

7 Citations (Scopus)

Fingerprint Dive into the research topics of 'Phase II trial of oral etoposide plus intravenous irinotecan in patients with platinum-resistant and taxane-pretreated ovarian cancer (JCOG0503)'. Together they form a unique fingerprint.

Medicine & Life Sciences